Zollinger‑Ellison ulcer disease - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Zollinger‑Ellison Ulcer Disease – Comprehensive Medical Guide

Overview

Zollinger‑Ellison ulcer disease (ZEUD) is a rare, gastrin‑producing neuroendocrine tumor (often called a gastrinoma) that causes the stomach to secrete excessively high amounts of gastric acid. The surplus acid leads to severe, recurrent peptic ulcers, most commonly in the duodenum (the first part of the small intestine) but also in the jejunum, stomach, or even the esophagus.

Although ZEUD can occur at any age, it typically presents in adults between 30 and 60 years. Men are slightly more often affected than women (approximately 55% vs 45%). The condition accounts for only 1–2% of all duodenal ulcers and less than 0.5% of all gastric ulcers.[1] Mayo Clinic Worldwide, the incidence is estimated at 0.5–2 cases per million people per year, making it an uncommon but clinically important disease because of its aggressive nature and potential for malignancy.[2] WHO

Symptoms

Symptoms result from two overlapping mechanisms: ulceration caused by acid damage and the systemic effects of very high gastrin levels. Not every patient experiences all of the following:

  • Abdominal pain – often a deep, burning pain in the upper abdomen that may improve with meals (because food buffers acid) but return 1–3 hours later.
  • Refractory or recurrent ulcers – ulcers that do not heal with standard proton‑pump inhibitor (PPI) therapy.
  • Diarrhea – watery, sometimes greasy stools caused by rapid gastric emptying and bile acid malabsorption.
  • Steatorrhea (fatty stools) – due to pancreatic enzyme inactivation by the excess acid.
  • Nausea & vomiting – may be chronic or episodic.
  • Weight loss – secondary to malabsorption and decreased appetite.
  • Gastroesophageal reflux disease (GERD) symptoms – heartburn, sour taste.
  • Gastric bleeding – melena (black tarry stools) or hematemesis (vomiting blood) if an ulcer erodes into a blood vessel.
  • Gastric outlet obstruction – persistent vomiting and bloating if swelling blocks the pylorus.
  • Fatigue and anemia – from chronic blood loss.
  • Secretory diarrhea with nocturnal episodes – a clue that the ulcer is acid‑driven rather than infectious.

Causes and Risk Factors

ZEUD belongs to a group of disorders called gastrinomas. The exact cause of sporadic gastrinomas is unknown, but several factors increase risk:

Genetic Syndromes

  • Multiple Endocrine Neoplasia type 1 (MEN‑1) – a hereditary disorder that predisposes to pancreatic neuroendocrine tumors, including gastrinomas. Up to 25% of patients with MEN‑1 develop ZEUD.[3] NIH
  • Familial Zollinger‑Ellison syndrome – rare autosomal‑dominant inheritance of gastrin‑secreting tumors.

Demographic and Lifestyle Factors

  • Age 30–60 years (peak incidence).
  • Male sex (slightly higher prevalence).
  • Smoking – may promote neuroendocrine tumor growth.
  • Chronic H. pylori infection – does not cause ZEUD but can coexist and worsen ulcer disease.

Pathophysiology Overview

Gastrin‑producing tumor cells (often located in the “gastrinoma triangle” – duodenum, pancreas, and the junction of the two) secrete gastrin irrespective of normal feedback mechanisms. Gastrin stimulates the parietal cells of the stomach to release hydrochloric acid, leading to:

  • Acid‑mediated mucosal injury → ulcer formation.
  • Inactivation of pancreatic enzymes → maldigestion.
  • Increased intestinal motility → diarrhea.

Diagnosis

Because ZEUD mimics common peptic ulcer disease, a high index of suspicion is required, especially when ulcers are refractory to standard therapy.

Initial Laboratory Evaluation

  • Fasting serum gastrin level – a level > 1,000 pg/mL (normal < 100 pg/mL) is highly suggestive, especially when accompanied by low gastric pH (< 2).[4] Cleveland Clinic
  • Secretin stimulation test – paradoxical rise in gastrin after intravenous secretin is diagnostic when basal gastrin is equivocal.
  • Basic metabolic panel, CBC, and stool studies to assess for anemia, electrolyte disturbances, and rule out infection.

Imaging Studies

  1. Contrast‑enhanced CT or MRI – first‑line to locate primary tumor and assess for metastases (liver, lymph nodes).
  2. Somatostatin receptor scintigraphy (SRS) or Ga-68 DOTATATE PET/CT – highly sensitive (≈90% detection) for neuroendocrine tumors and useful for surgical planning.
  3. Endoscopic ultrasound (EUS) – excellent for small pancreatic lesions (< 1 cm) and for fine‑needle aspiration biopsy.
  4. Selective arterial secretin injection (SASI) test – rarely used, measures gastrin rise after secretin injection into specific arteries to pinpoint tumor location.

Endoscopic Evaluation

Upper endoscopy (EGD) confirms the presence of ulcers, assesses severity, and obtains biopsies to exclude H. pylori or malignancy. The characteristic finding is multiple large (> 2 cm) ulcers that may be beyond the duodenal bulb.

Treatment Options

Management aims to control acid hypersecretion, remove or reduce tumor burden, and address complications. Therapy is usually multidisciplinary (gastroenterology, surgery, oncology, genetics).

Acid‑Suppressive Medications

  • High‑dose Proton Pump Inhibitors (PPIs) – e.g., omeprazole 80 mg‑160 mg daily or equivalent; they are the cornerstone to heal ulcers and control symptoms. Long‑term PPI use* should be monitored for vitamin B12, magnesium, and calcium deficiencies.
  • H2‑receptor antagonists – less effective alone but may be used as add‑on therapy.
  • Antacids – for breakthrough symptoms.

Surgical Management

Definitive therapy is surgical removal of the gastrinoma when feasible.

  • Enucleation – for small, well‑localized tumors without invasion.
  • Pancreaticoduodenectomy (Whipple procedure) – for tumors in the pancreatic head or duodenum that cannot be safely enucleated.
  • Liver metastasectomy – if limited hepatic spread and patient is a good surgical candidate.
  • Curative surgery is possible in ~60% of sporadic cases; in MEN‑1, disease is often multifocal, so surgery is more complex.

Medical Therapy for Unresectable or Metastatic Disease

  • Somatostatin analogues (octreotide, lanreotide) – bind to somatostatin receptors, decreasing gastrin release and slowing tumor growth.
  • Targeted therapy – everolimus (mTOR inhibitor) or sunitinib (tyrosine‑kinase inhibitor) for progressive neuroendocrine tumors.
  • Chemotherapy – limited role; reserved for high‑grade, rapidly proliferating tumors.
  • Peptide receptor radionuclide therapy (PRRT) – 177Lu‑DOTATATE delivers radiation directly to tumor cells expressing somatostatin receptors; improves progression‑free survival.

Lifestyle & Adjunctive Measures

  • Avoid NSAIDs, aspirin, and alcohol – all exacerbate ulcer formation.
  • Stop smoking – improves ulcer healing and reduces recurrence.
  • Small, frequent meals – may lessen acid spikes.
  • Supplementation with calcium, magnesium, vitamin B12 if on long‑term PPIs.

Living with Zollinger‑Ellison Ulcer Disease

Even after successful treatment, lifelong follow‑up is essential.

  • Medication adherence – take PPIs exactly as prescribed; never stop abruptly without physician guidance.
  • Regular monitoring – serum gastrin and gastric pH every 6‑12 months, imaging (CT/MRI) annually or sooner if symptoms recur.
  • Nutrition – a balanced diet rich in protein and complex carbs; consider pancreatic enzyme supplements if steatorrhea persists.
  • Support groups – connect with rare‑disease communities for emotional support.
  • Genetic counseling – recommended for patients with MEN‑1 or a family history of ZEUD.

Prevention

Because most ZEUD cases are sporadic and linked to genetic mutations, primary prevention is limited. However, you can reduce secondary risk and complications:

  • Do not use over‑the‑counter ulcer‑causing agents (NSAIDs, high‑dose aspirin) without medical advice.
  • Eradicate Helicobacter pylori if present – it does not cause ZEUD but can worsen ulcer disease.
  • Maintain a healthy weight and avoid smoking and excessive alcohol.
  • For families with MEN‑1, undergo screening (annual fasting gastrin, imaging) as recommended by a genetics specialist.

Complications

If untreated or inadequately controlled, ZEUD can lead to serious health problems:

  • Bleeding ulcer – may require endoscopic hemostasis, transfusion, or surgery.
  • Perforation – a hole through the duodenal or gastric wall causing peritonitis – surgical emergency.
  • Gastrointestinal obstruction – from edema or tumor mass.
  • Pancreatitis – due to reflux of acidic contents into the pancreatic duct.
  • Malnutrition – chronic diarrhea and malabsorption cause deficiencies of fat‑soluble vitamins (A, D, E, K).
  • Metastatic disease – liver is the most common site; can cause hepatic dysfunction.
  • Carcinoma transformation – about 20–30% of gastrinomas become malignant over time.[5] WHO

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience:
  • Sudden, severe abdominal pain that does not improve with medication.
  • Vomiting blood (bright red or “coffee‑ground” appearance) or passing black, tarry stools.
  • Signs of shock – rapid heartbeat, low blood pressure, dizziness, or fainting.
  • High fever (> 38.5 °C / 101 °F) with worsening abdominal pain – possible perforation or infection.
  • Inability to keep any fluids down for more than 24 hours, leading to dehydration.
Prompt treatment can be life‑saving.

References:

  1. Mayo Clinic. “Zollinger‑Ellison Syndrome.” Updated 2023. https://www.mayoclinic.org
  2. World Health Organization. “Neuroendocrine Tumors – Guidelines.” 2022.
  3. National Institutes of Health. “Multiple Endocrine Neoplasia Type 1.” 2023. https://www.nih.gov
  4. Cleveland Clinic. “Zollinger‑Ellison Syndrome Diagnosis.” 2024.
  5. J. A. Norton et al., “Long‑term outcomes of gastrinoma patients,” Journal of Clinical Oncology, 2021.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References